|
Delayed
NYSE
16:00:00 2025-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 8.610 USD | +0.23% |
|
-.--% | - |
| 25-09-17 | Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Microcap Index | CI |
| 25-09-17 | Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Index | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Biological Products | |||||||||
Discovery & Development of Novel Antibody Therapeutic Products to Treat Cancer | 20.75M | 34.9M | 65.27M | 84.82M | 87.68M | ||||
Total Assets | 132M | 213M | 141M | 128M | 120M | ||||
Interest Expense | - | - | -757K | - | - | ||||
Income Tax Expense | - | - | - | 561K | -146K | ||||
CAPEX | -175K | -967K | - | - | - | ||||
EBT | -119M | -55.28M | -95.57M | -20.87M | -29.81M | ||||
Gross Profit | - | - | - | - | 72.68M | ||||
D&A | 396K | 782K | 839K | 735K | 535K | ||||
Operating Income | -120M | -115M | -94.81M | -25.67M | -31.2M | ||||
Net Income | -119M | -55.28M | -95.57M | -21.43M | -29.67M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
United States | 20.75M | 34.9M | 46.26M | 67.81M | 65.98M | ||||
Total Assets | 132M | 213M | - | - | - | ||||
Interest Expense | - | - | - | - | - | ||||
D&A | 396K | 782K | - | - | - | ||||
CAPEX | -175K | -967K | - | - | - | ||||
Net Income | -119M | -55.28M | - | - | - | ||||
EBT | -119M | -55.28M | - | - | - | ||||
Operating Income | -120M | -115M | - | - | - | ||||
Eastern Asia | - | - | - | - | 7.46M | ||||
Latin America | - | - | - | - | 4.72M | ||||
Western Asia | - | - | - | - | 4.05M | ||||
Western Europe | - | - | - | - | 2.09M | ||||
Other Regions | - | - | - | - | 890K | ||||
Other Countries | - | - | 3.01M | 16.5M | - |
- Stock Market
- Stocks
- YMAB Stock
- Financials YMAS THER
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
